Sign in
Back
Acute Kidney Injury in a Patient on Tenofovir Alafenamide Fumarate After Initiation of Treatment for Hepatitis C Virus Infection
Journal article   Open access

Acute Kidney Injury in a Patient on Tenofovir Alafenamide Fumarate After Initiation of Treatment for Hepatitis C Virus Infection

David P Serota, Harold A Franch and Emily J Cartwright
Open forum infectious diseases, Vol.5(8), pp.ofy189-ofy189
2018
DOI: https://doi.org/10.1093/ofid/ofy189
PMCID: PMC6101585
PMID: 30151414

Abstract

Brief Reports acute kidney injury tenofovir alafenamide HIV infection hepatitis C
HIV treatment with tenofovir alafenamide fumarate (TAF) has decreased renal toxicity compared with tenofovir disoproxil fumarate in clinical trials. We report the case of a patient with HIV/HCV coinfection who was started on a TAF-based HIV regimen and developed acute kidney injury that worsened with the addition of sofosbuvir-ledipasvir.
url
https://doi.org/10.1093/ofid/ofy189View
Published (Version of record) Open

Metrics

12 Record Views
11 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.66 HIV
1.66.1372 Lipodystrophy
Web Of Science research areas
Immunology
Infectious Diseases
Microbiology
ESI research areas
Immunology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details